Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.91
ABC's Cash to Debt is ranked higher than
76% of the 67 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.47 vs. ABC: 0.91 )
ABC' s 10-Year Cash to Debt Range
Min: 0.07   Max: 1.38
Current: 0.91

0.07
1.38
Equity to Asset 0.09
ABC's Equity to Asset is ranked lower than
56% of the 66 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.42 vs. ABC: 0.09 )
ABC' s 10-Year Equity to Asset Range
Min: -0.16   Max: 0.38
Current: 0.09

-0.16
0.38
Interest Coverage 10.02
ABC's Interest Coverage is ranked higher than
61% of the 44 Companies
in the Global Medical Distribution industry.

( Industry Median: 10.02 vs. ABC: 10.02 )
ABC' s 10-Year Interest Coverage Range
Min: 1.87   Max: 60.07
Current: 10.02

1.87
60.07
F-Score: 6
Z-Score: 6.38
M-Score: -2.58
WACC vs ROIC
6.14%
2.92%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating margin (%) 0.43
ABC's Operating margin (%) is ranked higher than
52% of the 67 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.77 vs. ABC: 0.43 )
ABC' s 10-Year Operating margin (%) Range
Min: 0.65   Max: 2.09
Current: 0.43

0.65
2.09
Net-margin (%) 0.03
ABC's Net-margin (%) is ranked higher than
52% of the 67 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.25 vs. ABC: 0.03 )
ABC' s 10-Year Net-margin (%) Range
Min: 0.22   Max: 0.92
Current: 0.03

0.22
0.92
ROE (%) 1.74
ABC's ROE (%) is ranked lower than
52% of the 62 Companies
in the Global Medical Distribution industry.

( Industry Median: 12.17 vs. ABC: 1.74 )
ABC' s 10-Year ROE (%) Range
Min: 6.14   Max: 102.56
Current: 1.74

6.14
102.56
ROA (%) 0.16
ABC's ROA (%) is ranked higher than
52% of the 67 Companies
in the Global Medical Distribution industry.

( Industry Median: 4.09 vs. ABC: 0.16 )
ABC' s 10-Year ROA (%) Range
Min: 1.37   Max: 4.8
Current: 0.16

1.37
4.8
ROC (Joel Greenblatt) (%) 60.83
ABC's ROC (Joel Greenblatt) (%) is ranked higher than
90% of the 67 Companies
in the Global Medical Distribution industry.

( Industry Median: 23.12 vs. ABC: 60.83 )
ABC' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 20.87   Max: 184.06
Current: 60.83

20.87
184.06
Revenue Growth (3Y)(%) 20.80
ABC's Revenue Growth (3Y)(%) is ranked higher than
89% of the 55 Companies
in the Global Medical Distribution industry.

( Industry Median: 11.50 vs. ABC: 20.80 )
ABC' s 10-Year Revenue Growth (3Y)(%) Range
Min: 0   Max: 28.5
Current: 20.8

0
28.5
EBITDA Growth (3Y)(%) -5.20
ABC's EBITDA Growth (3Y)(%) is ranked higher than
51% of the 49 Companies
in the Global Medical Distribution industry.

( Industry Median: 10.10 vs. ABC: -5.20 )
ABC' s 10-Year EBITDA Growth (3Y)(%) Range
Min: 0   Max: 27
Current: -5.2

0
27
EPS Growth (3Y)(%) -21.60
ABC's EPS Growth (3Y)(%) is ranked lower than
55% of the 49 Companies
in the Global Medical Distribution industry.

( Industry Median: 13.30 vs. ABC: -21.60 )
ABC' s 10-Year EPS Growth (3Y)(%) Range
Min: 0   Max: 36.2
Current: -21.6

0
36.2
» ABC's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2014

ABC Guru Trades in Q1 2014

Joel Greenblatt 6,078 sh (New)
Louis Moore Bacon 6,132 sh (New)
Paul Tudor Jones 13,509 sh (New)
Ray Dalio 29,089 sh (+449.99%)
Ken Fisher 183,543 sh (-3.04%)
John Keeley 77,330 sh (-13.59%)
Steven Cohen 16,574 sh (-32.23%)
Jeremy Grantham 38,500 sh (-49.89%)
» More
Q2 2014

ABC Guru Trades in Q2 2014

Jim Simons 5,200 sh (New)
Ken Fisher 183,657 sh (+0.06%)
Louis Moore Bacon Sold Out
Paul Tudor Jones Sold Out
Jeremy Grantham Sold Out
Joel Greenblatt Sold Out
Ray Dalio Sold Out
John Keeley 76,984 sh (-0.45%)
» More
Q3 2014

ABC Guru Trades in Q3 2014

Jim Simons 359,800 sh (+6819.23%)
John Keeley 76,100 sh (-1.15%)
Ken Fisher 169,692 sh (-7.6%)
» More
Q4 2014

ABC Guru Trades in Q4 2014

Jeremy Grantham 77,800 sh (New)
Joel Greenblatt 84,032 sh (New)
Ray Dalio 8,784 sh (New)
Paul Tudor Jones 4,933 sh (New)
Jim Simons 1,545,700 sh (+329.6%)
John Keeley 73,535 sh (-3.37%)
Ken Fisher 135,278 sh (-20.28%)
» More
» Details

Insider Trades

Latest Guru Trades with ABC

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Joel Greenblatt 2014-12-31 New Buy0.06%$75.02 - $92.56 $ 103.120%84032
Ken Fisher 2014-12-31 Reduce -20.28%0.01%$75.02 - $92.56 $ 103.120%135278
Ray Dalio 2014-12-31 New Buy0.01%$75.02 - $92.56 $ 103.120%8784
Ray Dalio 2014-06-30 Sold Out 0.02%$62.83 - $73.66 $ 103.151%0
Joel Greenblatt 2014-06-30 Sold Out 0.01%$62.83 - $73.66 $ 103.151%0
Joel Greenblatt 2014-03-31 New Buy0.01%$64.11 - $71.38 $ 103.151%6078
Ray Dalio 2014-03-31 Add 449.99%0.01%$64.11 - $71.38 $ 103.151%29089
Ray Dalio 2013-12-31 Reduce -88.47%0.02%$61.19 - $70.89 $ 103.153%5289
Joel Greenblatt 2013-12-31 Sold Out 0.01%$61.19 - $70.89 $ 103.153%0
Ken Fisher 2013-12-31 Reduce -29.02%0.01%$61.19 - $70.89 $ 103.153%189305
Joel Greenblatt 2013-09-30 Reduce -95.6%0.18%$54.83 - $62.23 $ 103.176%3543
John Keeley 2013-09-30 Reduce -24.14%0.03%$54.83 - $62.23 $ 103.176%91863
Ray Dalio 2013-09-30 Add 65.99%0.01%$54.83 - $62.23 $ 103.176%45889
John Hussman 2013-06-30 Sold Out 0.19%$51.64 - $56.3 $ 103.190%0
Ray Dalio 2013-06-30 Reduce -58.27%0.02%$51.64 - $56.3 $ 103.190%27645
John Hussman 2013-03-31 New Buy0.19%$43.18 - $51.45 $ 103.1120%100000
John Keeley 2013-03-31 New Buy0.14%$43.18 - $51.45 $ 103.1120%139667
Joel Greenblatt 2013-03-31 Reduce -22.53%0.07%$43.18 - $51.45 $ 103.1120%92842
Ray Dalio 2013-03-31 Reduce -39.33%0.02%$43.18 - $51.45 $ 103.1120%66255
John Keeley 2012-12-31 Sold Out 0.16%$39.03 - $43.91 $ 103.1150%0
Ray Dalio 2012-12-31 Reduce -46.47%0.05%$39.03 - $43.91 $ 103.1150%109210
Ken Fisher 2012-12-31 Add 72.83%0.01%$39.03 - $43.91 $ 103.1150%218669
Chris Davis 2012-12-31 Sold Out 0.0015%$39.03 - $43.91 $ 103.1150%0
Andreas Halvorsen 2012-09-30 Sold Out 0.6%$37.36 - $39.78 $ 103.1166%0
John Keeley 2012-09-30 Reduce -65.63%0.32%$37.36 - $39.78 $ 103.1166%185401
Ken Fisher 2012-09-30 New Buy0.01%$37.36 - $39.78 $ 103.1166%126520
Chris Davis 2012-09-30 New Buy$37.36 - $39.78 $ 103.1166%943
John Keeley 2012-06-30 Reduce -26.38%0.16%$35.7 - $39.61 $ 103.1177%539491
Andreas Halvorsen 2012-06-30 Add 33.16%0.15%$35.7 - $39.61 $ 103.1177%1875500
Ray Dalio 2012-06-30 Reduce -24.62%0.05%$35.7 - $39.61 $ 103.1177%248910
Andreas Halvorsen 2012-03-31 Add 729.02%0.4%$36.19 - $40.09 $ 103.1191%1408500
Joel Greenblatt 2012-03-31 Add 76.09%0.19%$36.19 - $40.09 $ 103.1191%128834
John Keeley 2012-03-31 Reduce -25.12%0.19%$36.19 - $40.09 $ 103.1191%732766
Ray Dalio 2012-03-31 Add 103.82%0.1%$36.19 - $40.09 $ 103.1191%330210
Joel Greenblatt 2011-12-31 Add 106.08%0.17%$35.57 - $42.08 $ 103.1172%73162
Ray Dalio 2011-12-31 New Buy0.1%$35.57 - $42.08 $ 103.1172%162010
Andreas Halvorsen 2011-12-31 New Buy0.07%$35.57 - $42.08 $ 103.1172%169900
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 88.90
ABC's P/E(ttm) is ranked higher than
56% of the 73 Companies
in the Global Medical Distribution industry.

( Industry Median: 26.20 vs. ABC: 88.90 )
ABC' s 10-Year P/E(ttm) Range
Min: 11.12   Max: 88.93
Current: 88.9

11.12
88.93
Forward P/E 19.49
ABC's Forward P/E is ranked higher than
79% of the 73 Companies
in the Global Medical Distribution industry.

( Industry Median: 55.87 vs. ABC: 19.49 )
N/A
PE(NRI) 85.60
ABC's PE(NRI) is ranked higher than
56% of the 73 Companies
in the Global Medical Distribution industry.

( Industry Median: 26.40 vs. ABC: 85.60 )
ABC' s 10-Year PE(NRI) Range
Min: 9.93   Max: 85.82
Current: 85.6

9.93
85.82
P/B 12.80
ABC's P/B is ranked higher than
51% of the 73 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.68 vs. ABC: 12.80 )
ABC' s 10-Year P/B Range
Min: 1.24   Max: 12.8
Current: 12.8

1.24
12.8
P/S 0.20
ABC's P/S is ranked higher than
93% of the 73 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.78 vs. ABC: 0.20 )
ABC' s 10-Year P/S Range
Min: 0.09   Max: 0.2
Current: 0.2

0.09
0.2
PFCF 19.90
ABC's PFCF is ranked higher than
96% of the 73 Companies
in the Global Medical Distribution industry.

( Industry Median: 58.38 vs. ABC: 19.90 )
ABC' s 10-Year PFCF Range
Min: 3.51   Max: 50.58
Current: 19.9

3.51
50.58
POCF 16.26
ABC's POCF is ranked higher than
96% of the 73 Companies
in the Global Medical Distribution industry.

( Industry Median: 22.24 vs. ABC: 16.26 )
ABC' s 10-Year POCF Range
Min: 3.16   Max: 445.88
Current: 16.26

3.16
445.88
EV-to-EBIT 28.58
ABC's EV-to-EBIT is ranked higher than
63% of the 73 Companies
in the Global Medical Distribution industry.

( Industry Median: 17.67 vs. ABC: 28.58 )
ABC' s 10-Year EV-to-EBIT Range
Min: 6.6   Max: 31.3
Current: 28.58

6.6
31.3
PEG 19.45
ABC's PEG is ranked higher than
67% of the 73 Companies
in the Global Medical Distribution industry.

( Industry Median: 11.00 vs. ABC: 19.45 )
ABC' s 10-Year PEG Range
Min: 0.44   Max: 55.01
Current: 19.45

0.44
55.01
Shiller P/E 47.70
ABC's Shiller P/E is ranked higher than
71% of the 73 Companies
in the Global Medical Distribution industry.

( Industry Median: 41.02 vs. ABC: 47.70 )
ABC' s 10-Year Shiller P/E Range
Min: 13.51   Max: 47.7
Current: 47.7

13.51
47.7
Current Ratio 0.97
ABC's Current Ratio is ranked lower than
57% of the 67 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.50 vs. ABC: 0.97 )
ABC' s 10-Year Current Ratio Range
Min: 0.97   Max: 1.46
Current: 0.97

0.97
1.46
Quick Ratio 0.48
ABC's Quick Ratio is ranked lower than
58% of the 67 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.03 vs. ABC: 0.48 )
ABC' s 10-Year Quick Ratio Range
Min: 0.43   Max: 0.7
Current: 0.48

0.43
0.7
Days Inventory 27.01
ABC's Days Inventory is ranked higher than
89% of the 73 Companies
in the Global Medical Distribution industry.

( Industry Median: 52.56 vs. ABC: 27.01 )
ABC' s 10-Year Days Inventory Range
Min: 24.06   Max: 78.07
Current: 27.01

24.06
78.07
Days Sales Outstanding 21.03
ABC's Days Sales Outstanding is ranked higher than
93% of the 73 Companies
in the Global Medical Distribution industry.

( Industry Median: 56.12 vs. ABC: 21.03 )
ABC' s 10-Year Days Sales Outstanding Range
Min: 15.54   Max: 48.3
Current: 21.03

15.54
48.3

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 1.00
ABC's Dividend Yield is ranked lower than
83% of the 52 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.69 vs. ABC: 1.00 )
ABC' s 10-Year Dividend Yield Range
Min: 0.11   Max: 1.44
Current: 1

0.11
1.44
Dividend Payout 6.54
ABC's Dividend Payout is ranked higher than
53% of the 73 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.72 vs. ABC: 6.54 )
ABC' s 10-Year Dividend Payout Range
Min: 0.03   Max: 0.8
Current: 6.54

0.03
0.8
Dividend growth (3y) 29.80
ABC's Dividend growth (3y) is ranked higher than
88% of the 34 Companies
in the Global Medical Distribution industry.

( Industry Median: 13.90 vs. ABC: 29.80 )
ABC' s 10-Year Dividend growth (3y) Range
Min: 0   Max: 68.4
Current: 29.8

0
68.4
Yield on cost (5-Year) 4.53
ABC's Yield on cost (5-Year) is ranked higher than
62% of the 52 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.04 vs. ABC: 4.53 )
ABC' s 10-Year Yield on cost (5-Year) Range
Min: 0.5   Max: 6.53
Current: 4.53

0.5
6.53
Share Buyback Rate 5.40
ABC's Share Buyback Rate is ranked higher than
98% of the 51 Companies
in the Global Medical Distribution industry.

( Industry Median: -0.20 vs. ABC: 5.40 )
ABC' s 10-Year Share Buyback Rate Range
Min: 0   Max: -30.6
Current: 5.4

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 12.70
ABC's Price/Tangible Book is ranked lower than
66% of the 73 Companies
in the Global Medical Distribution industry.

( Industry Median: 6.37 vs. ABC: 12.70 )
ABC' s 10-Year Price/Tangible Book Range
Min: 3.96   Max: 755.5
Current: 12.7

3.96
755.5
Price/DCF (Projected) 1.70
ABC's Price/DCF (Projected) is ranked higher than
89% of the 73 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.74 vs. ABC: 1.70 )
ABC' s 10-Year Price/DCF (Projected) Range
Min: 0.66   Max: 2.9
Current: 1.7

0.66
2.9
Price/Median PS Value 1.50
ABC's Price/Median PS Value is ranked higher than
64% of the 73 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.33 vs. ABC: 1.50 )
ABC' s 10-Year Price/Median PS Value Range
Min: 0.73   Max: 2.08
Current: 1.5

0.73
2.08
Earnings Yield (Greenblatt) 3.50
ABC's Earnings Yield (Greenblatt) is ranked higher than
61% of the 66 Companies
in the Global Medical Distribution industry.

( Industry Median: 5.70 vs. ABC: 3.50 )
ABC' s 10-Year Earnings Yield (Greenblatt) Range
Min: 3.2   Max: 15.2
Current: 3.5

3.2
15.2
Forward Rate of Return (Yacktman) 5.29
ABC's Forward Rate of Return (Yacktman) is ranked higher than
52% of the 50 Companies
in the Global Medical Distribution industry.

( Industry Median: 14.50 vs. ABC: 5.29 )
ABC' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 5.3   Max: 31.8
Current: 5.29

5.3
31.8

Analyst Estimate

Sep15 Sep16 Sep17
Revenue(Mil) 97,160 92,122 142,974
EPS($) 4.54 5.11 5.82
EPS without NRI($) 4.54 5.11 5.82

Business Description

Industry: Medical Distribution » Medical Distribution
Compare:MCK, CAH, SHTDF, HSIC, PDCO » details
Traded in other countries:ABG.Germany,
AmerisourceBergen Corp is a Delaware Corporation and was formed in 2001. It is a pharmaceutical services company, with operations mainly in the United States and Canada. Servicing both healthcare providers and pharmaceutical manufacturers in the pharmaceutical supply channel, it provides drug distribution and related services designed to reduce costs and improve patient outcomes. The Company distributes a comprehensive offering of brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a wide variety of healthcare providers mainly located in the United States and Canada, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical and dialysis clinics, physicians, long-term care and other alternate site pharmacies, and other customers. The Company also provides pharmacy services to certain specialty drug patients. Additionally, it furnishes healthcare providers and pharmaceutical manufacturers with an assortment of related services, including pharmaceutical packaging, pharmacy automation, inventory management, reimbursement and pharmaceutical consulting services, logistics services, and pharmacy management. It currently serves its customers (healthcare providers, pharmaceutical manufacturers, and certain specialty drug patients) through a geographically diverse network of distribution service centers and other operations in the United States and Canada, and through packaging facilities in the United States and the United Kingdom. The Company's national competitors are Cardinal Health, Inc. (Cardinal) and McKesson Corporation (McKesson). It is subject to oversight by various federal and state governmental entities and it is subject to, and affected by, a variety of federal and state laws, regulations and policies.
» More Articles for ABC

Headlines

Articles On GuruFocus.com
Wasatch International Growth Fund Comments on Abcam Jun 05 2014 


More From Other Websites
Acquisition of own shares Mar 02 2015
Acquisition of own shares Mar 02 2015
Acquisition of own shares Feb 26 2015
Acquisition of own shares Feb 25 2015
AmerisourceBergen Completes Tender Offer for Outstanding Shares of MWI Veterinary Supply, Inc. Feb 24 2015
AmerisourceBergen Completes Acquisition of MWI Veterinary Supply, Inc. Feb 24 2015
Express Scripts (ESRX) Beats on Q4 Earnings & Revenues - Analyst Blog Feb 24 2015
AmerisourceBergen Completes Tender Offer for Outstanding Shares of MWI Veterinary Supply, Inc. Feb 24 2015
Acquisition of own shares Feb 24 2015
CR Bard's Lutonix DCB Gets Pass-Through Payment Approval - Analyst Blog Feb 23 2015
Acquisition of own shares Feb 21 2015
AMERISOURCEBERGEN CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a... Feb 20 2015
LabCorp Beats Q4 Earnings, Positive on Covance Addition - Analyst Blog Feb 20 2015
Acquisition of own shares Feb 20 2015
Acquisition of own shares Feb 19 2015
AMERISOURCEBERGEN CORP Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial... Feb 18 2015
Acquisition of own shares Feb 18 2015
Vascular Solutions Set to Join the S&P SmallCap 600 Feb 17 2015
Amerisource wows with US$9bn book for US$1bn deal Feb 17 2015
AmerisourceBergen Prices $500 Million 3.25% Senior Notes Due 2025 and $500 Million 4.25% Senior... Feb 17 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK